Trials / Completed
CompletedNCT03712241
Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults
A Phase I, Open-label, Randomized, 4-period Crossover Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of K-285 Compared With a Single Oral Dose of Indomethacin Capsule in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Kowa Research Institute, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study is to compare the PK parameters of multiple doses and applications of K-285 with a single dose of indomethacin capsule.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-285 | Topical |
| DRUG | Indomethacin | Capsule |
Timeline
- Start date
- 2018-10-04
- Primary completion
- 2019-01-06
- Completion
- 2019-01-06
- First posted
- 2018-10-19
- Last updated
- 2019-01-17
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03712241. Inclusion in this directory is not an endorsement.